Identification of the First Nonpeptidergic Inverse Agonist for a Constitutively Active Viral-encoded G Protein-coupled Receptor*

Human cytomegalovirus (HCMV) encodes a G protein-coupled receptor (GPCR), named US28, which shows homology to chemokine receptors and binds several chemokines with high affinity. US28 induces migration of smooth muscle cells, a feature essential for the development of atherosclerosis, and may serve as a co-receptor for human immunodeficiency virus-type 1 entry into cells. Previously, we have shown that HCMV-encoded US28 displays constitutive activity, whereas its mammalian homologs do not. In this study we have identified a small nonpeptidergic molecule (VUF2274) that inhibits US28-mediated phospholipase C activation in transiently transfected COS-7 cells and in HCMV-infected fibroblasts. Moreover, VUF2274 inhibits US28-mediated HIV entry into cells. In addition, VUF2274 fully displaces radiolabeled RANTES (regulated on activation normal T cell expressed and secreted) binding at US28, apparently with a noncompetitive behavior. Different analogues of VUF2274 have been synthesized and pharmacologically characterized, to understand which features are important for its inverse agonistic activity. Finally, by means of mutational analysis of US28, we have identified a glutamic acid in transmembrane 7 (TM 7), which is highly conserved among chemokine receptors, as a critical residue for VUF2274 binding to US28. The identification of a full inverse agonist provides an important tool to investigate the relevance of US28 constitutive activity in viral pathogenesis.

[1]  T. Albrecht,et al.  Hydrolysis of inositol lipids: an early signal of human cytomegalovirus infection , 1988, Archives of Virology.

[2]  T. Schwartz,et al.  Murine Cytomegalovirus (CMV) M33 and Human CMV US28 Receptors Exhibit Similar Constitutive Signaling Activities , 2002, Journal of Virology.

[3]  T. Hope,et al.  Association of Chemokine-mediated Block to HIV Entry with Coreceptor Internalization* , 2002, The Journal of Biological Chemistry.

[4]  R. Leurs,et al.  The Rat Cytomegalovirus R33-Encoded G Protein-Coupled Receptor Signals in a Constitutive Fashion , 2002, Journal of Virology.

[5]  R. Leurs,et al.  Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. , 2001, Molecular pharmacology.

[6]  J. Virelizier,et al.  Latently Infected Thp-1 Monocytes Receptor Gene Us28 Is Transcribed in Human Cytomegalovirus Chemokine , 2000 .

[7]  T. Schwartz,et al.  Virally encoded 7TM receptors , 2001, Oncogene.

[8]  P. Murphy.  Viral exploitation and subversion of the immune system through chemokine mimicry , 2001, Nature Immunology.

[9]  Rob Leurs,et al.  Constitutive Signaling of the Human Cytomegalovirus-encoded Chemokine Receptor US28* , 2001, The Journal of Biological Chemistry.

[10]  E. Lavi,et al.  Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. , 2000, Experimental and molecular pathology.

[11]  M. Peck,et al.  A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3 , 2000, The Journal of Biological Chemistry.

[12]  Frank Diehl,et al.  Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor Antagonists , 2000, The Journal of Biological Chemistry.

[13]  S. O. Smith,et al.  A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Palczewski,et al.  X-Ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. , 2000, Journal of structural biology.

[15]  Cecilia Soderberg-Naucler,et al.  The Human Cytomegalovirus Chemokine Receptor US28 Mediates Vascular Smooth Muscle Cell Migration , 1999, Cell.

[16]  R. Leurs,et al.  Mutational Analysis of the Antagonist-binding Site of the Histamine H1 Receptor* , 1999, The Journal of Biological Chemistry.

[17]  M. Schluchter,et al.  CYTOMEGALOVIRUS INFECTION AND HIV-1 DISEASE PROGRESSION IN INFANTS BORN TO HIV-1–INFECTED WOMEN , 1999 .

[18]  M. Maccoss,et al.  Characterization of a Novel, Non-peptidyl Antagonist of the Human Glucagon Receptor* , 1999, The Journal of Biological Chemistry.

[19]  B. Bodaghi,et al.  Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types. , 1999, The Journal of general virology.

[20]  Thomas N. Kledal,et al.  Agonists and Inverse Agonists for the Herpesvirus 8-encoded Constitutively Active Seven-transmembrane Oncogene Product, ORF-74* , 1999, The Journal of Biological Chemistry.

[21]  T. Schwartz,et al.  Selective recognition of the membrane‐bound CX3C chemokine, fractalkine, by the human cytomegalovirus‐encoded broad‐spectrum receptor US28 , 1998, FEBS letters.

[22]  T. Schall,et al.  Functional Analysis of the Human Cytomegalovirus US28 Gene by Insertion Mutagenesis with the Green Fluorescent Protein Gene , 1998, Journal of Virology.

[23]  C. Vita,et al.  Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells , 1998, The Journal of experimental medicine.

[24]  P. Murphy,et al.  The N-terminal Extracellular Segments of the Chemokine Receptors CCR1 and CCR3 Are Determinants for MIP-1α and Eotaxin Binding, Respectively, but a Second Domain Is Essential for Efficient Receptor Activation* , 1998, The Journal of Biological Chemistry.

[25]  D. Taub,et al.  Identification and Characterization of Small Molecule Functional Antagonists of the CCR1 Chemokine Receptor* , 1998, The Journal of Biological Chemistry.

[26]  E. Cesarman,et al.  G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.

[27]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[28]  V. Ferrans,et al.  Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells. , 1997, The Journal of clinical investigation.

[29]  I. Charo,et al.  The Amino-terminal Domain of CCR2 Is Both Necessary and Sufficient for High Affinity Binding of Monocyte Chemoattractant Protein 1 , 1997, The Journal of Biological Chemistry.

[30]  N. Heveker,et al.  Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. , 1997, Science.

[31]  E. Cesarman,et al.  Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.

[32]  C. J. Beall,et al.  The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. , 1995, Biochemical and biophysical research communications.

[33]  P. Murphy,et al.  Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. , 1994, The Journal of biological chemistry.

[34]  M. Debakey,et al.  Cytomegalovirus DNA in arterial walls of patients with atherosclerosis , 1994, Journal of medical virology.

[35]  T. Vanden Bos,et al.  Importance of the amino terminus of the interleukin-8 receptor in ligand interactions. , 1993, The Journal of biological chemistry.

[36]  M. Debakey,et al.  Cytomegalovirus and atherosclerosis. , 1993, European heart journal.

[37]  B. Barrell,et al.  Human cytomegalovirus encodes three G protein-coupled receptor homologues , 1990, Nature.

[38]  T. Albrecht,et al.  Human cytomegalovirus stimulates arachidonic acid metabolism through pathways that are affected by inhibitors of phospholipase A2 and protein kinase C. , 1990, Biochemical and biophysical research communications.

[39]  M. Fons,et al.  Cell activation signals and the pathogenesis of human cytomegalovirus. , 1990, Intervirology.

[40]  C. Wiley,et al.  HIV and HCMV coinfect brain cells in patients with AIDS. , 1988, Virology.

[41]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.